Overview

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

Status:
Withdrawn
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the usefulness of oral fish oil(Lovaza)in normalizing liver function in patients who have parenteral nutrition associated liver disease. The investigators believe that patients who take oral fish oil will normalize liver function faster than those who do not
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Boston Children's Hospital
Boston Children’s Hospital
Collaborators:
GlaxoSmithKline
Harvard University